Abstract
Refractory anemia with excess blasts in transformation (RAEB-T) is a subgroup of myelodysplastic syndrome (MDS) in which the bone marrow blast count ranges from 20% to 30%. The recently proposed World Health Organization Classification of Hematologic Malignancies eliminated this category from MDS by lowering the blast count cutoff for acute myeloid leukemia (AML) from 30% to 20%. However, MDS is distinguished from AML by a significant increase in apoptosis. To investigate the difference in apoptosis between RAEB-T, AML, and other categories of MDS, we prospectively analyzed fresh bone marrow samples using the Annexin V and mitochondrial potential assays. There was a significantly higher level of apoptosis in RAEB-T than in AML according to both assays, while no significant differences between RAEB-T and other categories of MDS were noted. The data suggest that RAEB-T is more likely to be an advanced stage of MDS and biologically different from AML.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Sultan C . The French–American–British (FAB) Co-operative Group. Proposals for the classification of the myelodysplastic syndromes Br J Haematol 1982 51: 189–199
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD . World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue. Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 J Clin Oncol 1999 17: 3835–3849
Yoshida Y . Hypothesis: apoptosis may be the mechanism responsible for the premature intramedullary cell death in the myelodysplastic syndrome Leukemia 1993 7: 144–146
Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A . Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes Blood 1995 86: 268–276
Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A . Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis Am J Hematol 1995 48: 143–154
Rajapaksa R, Ginzton JP, Rott LS, Greenberg PL . Altered oncoprotein expression and apoptosis in myelodysplastic syndromemarrow cells Blood 1996 88: 4275–4287
Merchant SH, Gonchoroff NJ, Hutchison RE . Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes Cytometry 2001 46: 28–32
Irvine AE, Magill MK, Somerville LE, McMullin MF . Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia Exp Hematol 1998 26: 435–439
Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A . The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS Blood 2000 96: 3932–3938
Albitar M, Beran M, O'Brien S, Kantarjian H, Freireich E, Keating M, Estey E . Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia Blood 2000 96: 372–373
Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C . A novel assay for apoptosis. Flow cytometric detection of phosphatidyl serine expression on early apoptotic cells using fluorescein labeled Annexin V J Immunol Meth 1995 164: 39–51
Green DR, Reed JC . Mitochondria and apoptosis Science 1998 281: 1309–1312
Suzuki K, Kostin S, Person V, Elsasser A, Schaper J . Time course of the apoptotic cascade and effects of caspase inhibitors in adult rat ventricular cardiomyocytes J Mol Cell Cardiol 2001 33: 983–994
Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C . A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic action 5, 5’, 6, 6’-tetrachloro-1,1’,3,3’-tetraethylbenzimidazolcarbocyanine iodide Biochem Biophy Res Commun 1993 197: 40–45
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Huh, Y., Jilani, I., Estey, E. et al. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia. Leukemia 16, 2249–2252 (2002). https://doi.org/10.1038/sj.leu.2402704
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402704
Keywords
This article is cited by
-
Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling
Cell Communication and Signaling (2017)
-
Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors
Current Hematologic Malignancy Reports (2012)
-
Integrative analysis of next generation sequencing for small non-coding RNAs and transcriptional regulation in Myelodysplastic Syndromes
BMC Medical Genomics (2011)
-
Expression of APO2.7, bcl-2 and bax apoptosis-associated proteins in CD34− bone marrow cell compartments from patients with myelodysplastic syndromes
Leukemia (2004)